Beta blockers, used for decades after heart attacks, provide no benefit for patients with preserved heart function, according to the REBOOT trial. The massive study also found women faced higher risks when taking the drug. Experts say the results will change heart treatment guidelines worldwide.
Quelle: ScienceDaily | Allergy
Titelbild/Grafik: ScienceDaily News
Weiteres von ScienceDaily | Allergy
- A quiet change in everyday foods could save thousands of lives
- Scientists may have been wrong about what causes asthma
- Alzheimer’s may trick the brain into erasing its own memories
- This new antibody may stop one of the deadliest breast cancers
- Why some people get bad colds and others don’t
- Stanford scientists found a way to regrow cartilage and stop arthritis
- A common painkiller may be quietly changing cancer risk
- Vitamin A may be helping cancer hide from the immune system
- Long COVID may be fueled by inflammation and tiny clots
- A global cancer surge is underway and the world is not ready
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
